Group 1 - The core viewpoint of the news is that Shuiyang Co., Ltd. has shown significant stock performance and financial growth in 2023, with a notable increase in share price and revenue [1][2][3] Group 2 - As of December 31, Shuiyang's stock price increased by 2.02% to 22.20 CNY per share, with a total market capitalization of 8.658 billion CNY [1] - Year-to-date, Shuiyang's stock price has risen by 67.93%, with a 10.67% increase over the past 20 days [2] - The company reported a revenue of 3.409 billion CNY for the period from January to September 2025, reflecting a year-on-year growth of 11.96%, and a net profit of 136 million CNY, up 44.01% [2] - The main business revenue composition includes 81.84% from creams, 17.32% from masks, and 0.84% from other products [2] - Shuiyang has distributed a total of 142 million CNY in dividends since its A-share listing, with 77.8142 million CNY in the last three years [3] - As of September 30, 2025, the number of shareholders increased by 10.64% to 30,000, while the average circulating shares per person decreased by 9.61% to 11,966 shares [2][3]

12月23日，水羊股份盘中下跌2.01%，截至13:58，报21.45元/股，成交2.10亿元，换手率2.70%，总市值 83.66亿元。 资金流向方面，主力资金净流出2662.74万元，特大单买入810.84万元，占比3.87%，卖出1518.57万元， 占比7.25%；大单买入4286.97万元，占比20.46%，卖出6241.99万元，占比29.79%。 分红方面，水羊股份A股上市后累计派现1.42亿元。近三年，累计派现7781.42万元。 机构持仓方面，截止2025年9月30日，水羊股份十大流通股东中，香港中央结算有限公司位居第六大流 通股东，持股818.33万股，相比上期增加565.94万股。华夏内需驱动混合A（011278）位居第八大流通 股东，持股162.08万股，为新进股东。财通资管消费升级一年持有期混合A（010715）位居第十大流通 股东，持股107.99万股，为新进股东。贝莱德中国新视野混合A（013426）退出十大流通股东之列。 责任编辑：小浪快报 今年以来水羊股份已经1次登上龙虎榜，最近一次登上龙虎榜为5月28日，当日龙虎榜净买入2448.89万 元；买入总计2.08亿元 ，占总成交 ...

珀莱雅今年以来股价跌17.12%，近5个交易日涨1.27%，近20日跌3.88%，近60日跌14.14%。 今年以来珀莱雅已经1次登上龙虎榜，最近一次登上龙虎榜为4月28日。 12月19日，珀莱雅盘中上涨2.01%，截至14:29，报68.56元/股，成交2.99亿元，换手率1.11%，总市值 271.48亿元。 资金流向方面，主力资金净流入343.24万元，特大单买入1520.82万元，占比5.09%，卖出2159.92万元， 占比7.24%；大单买入6223.36万元，占比20.85%，卖出5241.02万元，占比17.56%。 资料显示，珀莱雅化妆品股份有限公司位于浙江省杭州市西湖区西溪路588号珀莱雅大厦,香港铜锣湾希 慎道33号利园1期19楼1919室，成立日期2006年5月24日，上市日期2017年11月15日，公司主营业务涉及 化妆品的研发、生产和销售。主营业务收入构成为：珀莱雅品牌74.19%，其他品牌25.70%，其他(补 充)0.11%。 分红方面，珀莱雅A股上市后累计派现21.25亿元。近三年，累计派现15.40亿元。 机构持仓方面，截止2025年9月30日，珀莱雅十大流通股东中，香港中 ...

Core Viewpoint - Water Sheep Co., Ltd. has experienced fluctuations in stock price and trading volume, with a notable increase in revenue and profit year-on-year, indicating potential growth in the cosmetics sector [1][2]. Company Performance - As of December 2, Water Sheep's stock price was 19.93 yuan per share, down 2.02%, with a total market capitalization of 7.773 billion yuan [1]. - The company has seen a 50.76% increase in stock price year-to-date, with a 3.00% rise in the last five trading days, but a decline of 1.48% over the last 20 days and 11.34% over the last 60 days [1]. - For the period from January to September 2025, Water Sheep achieved a revenue of 3.409 billion yuan, representing a year-on-year growth of 11.96%, and a net profit of 136 million yuan, up 44.01% year-on-year [2]. Shareholder and Institutional Holdings - As of November 10, the number of shareholders increased to 30,000, a rise of 10.64%, while the average circulating shares per person decreased by 9.61% to 11,966 shares [2]. - The company has distributed a total of 142 million yuan in dividends since its A-share listing, with 77.8142 million yuan distributed over the past three years [3]. - Notable institutional shareholders include Hong Kong Central Clearing Limited, which increased its holdings by 5.6594 million shares, and new entrants such as Huaxia Domestic Demand Driven Mixed A and Caitong Asset Management [3]. Business Overview - Water Sheep Co., Ltd. specializes in the research, production, and sales of cosmetics, with its main revenue sources being lotions and creams (81.84%), masks (17.32%), and other products (0.84%) [1]. - The company operates within the beauty care sector, specifically in branded cosmetics, and is associated with concepts such as DeepSeek, new retail, and Xiaomi [2].

Core Viewpoint - Marubi Biotechnology's stock has shown fluctuations in recent trading sessions, with a year-to-date increase of 8.63% and a recent decline over the past 60 days of 15.88% [1][2]. Company Overview - Marubi Biotechnology Co., Ltd. was established on April 2, 2002, and went public on July 25, 2019. The company is located in Guangzhou and specializes in the research, design, production, sales, and service of various skincare products [1]. - The revenue composition of Marubi includes skincare products (39.05%), beauty and other products (29.37%), eye care products (23.81%), cleansing products (7.67%), and other businesses (0.10%) [1]. Financial Performance - For the period from January to September 2025, Marubi achieved a revenue of 2.45 billion yuan, representing a year-on-year growth of 25.51%. The net profit attributable to the parent company was 244 million yuan, with a growth of 2.13% [2]. - Since its A-share listing, Marubi has distributed a total of 1.08 billion yuan in dividends, with 710 million yuan distributed over the past three years [3]. Shareholder Information - As of September 30, 2025, the number of shareholders for Marubi was 18,900, an increase of 8.86% from the previous period. The average number of circulating shares per person was 21,205, a decrease of 8.14% [2]. - Among the top ten circulating shareholders, several funds from the Fortune series hold significant stakes, with the largest being Fortune Consumption Theme Mixed A, holding 3.69 million shares [3].

Core Viewpoint - Water Goat Co., Ltd. has shown a significant increase in stock price this year, but recent trading indicates a decline in the short term, raising questions about future performance and investor sentiment [1][2]. Financial Performance - For the period from January to September 2025, Water Goat achieved a revenue of 3.409 billion yuan, representing a year-on-year growth of 11.96%. The net profit attributable to shareholders was 136 million yuan, reflecting a substantial increase of 44.01% compared to the previous year [2]. - The company has distributed a total of 142 million yuan in dividends since its A-share listing, with 77.8142 million yuan distributed over the past three years [3]. Stock Market Activity - As of November 25, Water Goat's stock price rose by 2.09% to 19.50 yuan per share, with a trading volume of 174 million yuan and a turnover rate of 2.50%, resulting in a total market capitalization of 7.605 billion yuan [1]. - The stock has increased by 47.50% year-to-date, but has seen a decline of 9.89% over the last five trading days, 11.84% over the last 20 days, and 9.60% over the last 60 days [1]. Shareholder Structure - As of November 10, the number of shareholders for Water Goat increased to 30,000, a rise of 10.64%. The average number of circulating shares per shareholder decreased by 9.61% to 11,966 shares [2]. - Notable changes in institutional holdings include Hong Kong Central Clearing Limited becoming the sixth largest shareholder with 8.1833 million shares, an increase of 5.6594 million shares from the previous period. New shareholders include Huaxia Domestic Demand Driven Mixed A and Caitong Asset Management [3]. Business Overview - Water Goat Co., Ltd. is based in Changsha, Hunan Province, and was established on November 1, 2012. It was listed on February 8, 2018. The company's main business involves the research, production, and sales of cosmetics, with the primary revenue sources being lotions and creams (81.84%), masks (17.32%), and other products (0.84%) [1][2].

Core Viewpoint - Marubi Biotechnology's stock has shown fluctuations in recent trading, with a current price of 33.64 CNY per share and a market capitalization of 13.49 billion CNY, reflecting a year-to-date increase of 6.76% [1] Financial Performance - For the period from January to September 2025, Marubi Biotechnology achieved a revenue of 2.45 billion CNY, representing a year-on-year growth of 25.51%, while the net profit attributable to shareholders was 244 million CNY, up 2.13% year-on-year [2] - Cumulative cash dividends since the company's A-share listing amount to 1.08 billion CNY, with 710 million CNY distributed over the past three years [3] Stock Market Activity - As of November 25, 2023, Marubi's stock price increased by 2.25% during the trading session, with a trading volume of approximately 79.75 million CNY and a turnover rate of 0.60% [1] - The stock has appeared on the "Dragon and Tiger List" once this year, with the most recent occurrence on August 25, 2023, where it recorded a net buy of -779.08 million CNY [1] Shareholder Information - As of September 30, 2025, the number of shareholders increased by 8.86% to 18,900, with an average of 21,205 circulating shares per shareholder, a decrease of 8.14% [2] - Among the top ten circulating shareholders, several funds maintained their holdings, while Hong Kong Central Clearing Limited exited the list [3]

Core Viewpoint - The stock of Furuida has experienced a decline, with a current price of 7.75 yuan per share and a market capitalization of 7.878 billion yuan, reflecting a challenging financial performance in recent periods [1][2]. Company Performance - Furuida's stock price has increased by 3.33% year-to-date, but it has seen a decline of 3.00% over the last five trading days, 1.77% over the last 20 days, and 9.57% over the last 60 days [1]. - For the period from January to September 2025, Furuida reported a revenue of 2.597 billion yuan, a year-on-year decrease of 7.34%, and a net profit attributable to shareholders of 142 million yuan, down 17.19% year-on-year [2]. Shareholder and Market Activity - As of September 30, 2025, Furuida had 44,500 shareholders, a decrease of 6.27% from the previous period, with an average of 22,827 circulating shares per shareholder, an increase of 6.69% [2]. - The company has made cumulative cash distributions of 1.196 billion yuan since its A-share listing, with 213 million yuan distributed over the last three years [3]. Institutional Holdings - Among the top ten circulating shareholders, the Southern CSI 1000 ETF holds 4.6498 million shares, having decreased its holdings by 70,900 shares compared to the previous period [3].

Core Viewpoint - Shanghai Jahwa's stock price has experienced fluctuations, with a year-to-date increase of 39.41% but a recent decline in the last five and twenty trading days [1][2]. Group 1: Stock Performance - As of November 20, Shanghai Jahwa's stock price was 23.52 CNY per share, with a market capitalization of 15.81 billion CNY [1]. - The stock has seen a net outflow of 5.51 million CNY in principal funds, with large orders accounting for 8.90% of total buying and 19.60% of total selling [1]. - Year-to-date, the stock has risen by 39.41%, but it has dropped by 4.39% in the last five trading days and 11.74% in the last twenty trading days [1]. Group 2: Financial Performance - For the period from January to September 2025, Shanghai Jahwa reported a revenue of 4.96 billion CNY, representing a year-on-year growth of 10.83%, and a net profit attributable to shareholders of 405 million CNY, which is a 149.12% increase year-on-year [2]. - The company has cumulatively distributed 3.595 billion CNY in dividends since its A-share listing, with 344 million CNY distributed in the last three years [3]. Group 3: Shareholder Information - As of September 30, 2025, the number of shareholders for Shanghai Jahwa was 29,600, a decrease of 21.58% from the previous period, while the average circulating shares per person increased by 27.52% to 22,704 shares [2]. - The second-largest circulating shareholder is Hong Kong Central Clearing Limited, holding 36.55 million shares, an increase of 3.77 million shares from the previous period [3].

Core Viewpoint - The stock of Betaini has experienced a decline, with a current price of 42.74 CNY per share, reflecting a decrease of 2.02% on November 20. The company has faced a net outflow of funds and a significant drop in revenue and profit year-on-year [1][2]. Company Overview - Betaini, established on May 13, 2010, and listed on March 25, 2021, is based in Kunming, Yunnan Province. The company focuses on skincare products under the "Winona" brand, utilizing natural plant active ingredients, primarily targeting sensitive skin [1]. - The revenue composition of Betaini includes skincare products (84.36%), makeup (10.07%), medical devices (4.88%), and other services (0.70%) [1]. Financial Performance - For the period from January to September 2025, Betaini reported a revenue of 3.464 billion CNY, a year-on-year decrease of 13.78%. The net profit attributable to the parent company was 272 million CNY, down 34.45% compared to the previous year [2]. - Since its A-share listing, Betaini has distributed a total of 1.289 billion CNY in dividends, with 844 million CNY distributed over the last three years [3]. Shareholder Information - As of November 10, 2025, the number of shareholders for Betaini increased to 39,700, with an average of 10,681 circulating shares per person, a decrease of 3.79% [2]. - The top ten circulating shareholders include Hong Kong Central Clearing Limited and E Fund's ChiNext ETF, with notable changes in their holdings [3].